CD Bioparticles Announces Advanced Cellulose Nanoparticles For Multiple Biomedical Applications
CD Bioparticles announces the launch of its new line of Cellulose Nanoparticles. NEW YORK, NY, UNITED STATES, February 21, 2025 /EINPresswire ...
CD Bioparticles Launches Exosome Extraction Kits To Support Exosome Research
CD Bioparticles recently announced the availability of its new line of Exosome Extraction Kits. NEW YORK, NY, UNITED STATES, February 21, 2025 ...
Study highlights successes of Virginia's oyster restoration efforts
Virginia has made significant investments in the restoration of oyster reefs in the Chesapeake Bay, and now a study led by ...
Creative progress or mass theft? Why a major AI art auction is provoking wonder—and outrage
Thirty-four artworks created with artificial intelligence (AI) have gone up for sale at Christie's in New York, in the famed ...
Business Insider23 小时
Biotech Alert: Searches spiking for these stocks today
Bio-Path is a biotechnology company developing DNAbilize, a novel technology that has yielded a pipeline of RNAi nanoparticle drugs that can be administered with a simple intravenous infusion.
The Economist18 小时
CRISPR cures face cost and safety concerns
Doctors harvest stem cells from the patient’s bone marrow and then send them off to a lab, where CRISPR is used to turn up the production of another, functional version of haemoglobin. This version is ...